RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The next week will be monumental. Think of the value instead of 10 separate tests at $200-400 each a simple single test for 10 cancers single priced utilizing the covid and telehealth partners. Millions in covid revenue and than roll right into Aristotle using the same logistics. Let's go
RelevantStock wrote: SAGDollar wrote: I think Mercer will be a teriffic partner to market Aristotle
Ah yeah definitely the best. Aristotle will benefit the most to the employers that offer insurance plans to a large pool of workers, allowig them to save huge costs on cancer treatments (in USA). I am here mostly for covid revenue for the moment though, as much as I like Aristotle and believe in its future. Glad they are working on following the prospectus plan, I have them in high respect for helping fight the pandemic, but I'll need to better see a big lighthouse to stay onboard after the Q3 hype. I was 100% believer but would have liked a follow up PR or two, after a (first) very abrupt ER for q4 q1.